Article Data

  • Views 2822
  • Dowloads 137

Case Reports

Open Access

Small cell ovarian carcinoma hypercalcemic type and endometrial adenocarcinoma in a 49-year-old patient: a very rare case

  • S. Kalogeropoulos1
  • E. Chronopoulou1,*,
  • E. Kourea2
  • A. Siampalis1
  • A. Kaponis1
  • G. O Decavalas1

1Department of Obstetrics and Gynaecology, Greece

2Department of Pathology, Patras University, School of Medicine. University General Hospital of Patras, Patras (Greece)

DOI: 10.12892/ejgo4978.2019 Vol.40,Issue 6,December 2019 pp.1064-1066

Published: 10 December 2019

*Corresponding Author(s): E. Chronopoulou E-mail: elpiniki.chronopoulou.12@alumni.ucl.ac.uk

PDF (763.53 kB) View Full-text

Abstract

Background: Small cell ovarian carcinoma hypercalcemic type (SCCOHT) is a rare ovarian malignancy with less than 400 cases worldwide. However, it affects mainly young women and has poor prognosis. The incidence of concurrent endometrial and ovarian cancer is as low as 10%, and has not been described, to our knowledge, with SCCOHT. Case Report: This is a rare case of a 49-year-old female who presented with abdominal pain, constipation, asymptomatic hypercalcemia, a large palpable abdominal mass, and was diagnosed with SCCOHT with concurrent Grade I endometrial adenocarcinoma endometroid type. Conclusion: This is an interesting case due to the concurrent endometrial cancer, the size of the tumor, and the age of the patient and aims to increase clinical suspicion around SCCOHT. The importance of the MDT should be highlighted, especially for this type of tumors which can be a diagnostic and treatment challenge.

Keywords

Ovarian cancer; Small cell ovarian carcinoma; Endometrial cancer.

Cite and Share

S. Kalogeropoulos, E. Chronopoulou, E. Kourea, A. Siampalis, A. Kaponis, G. O Decavalas. Small cell ovarian carcinoma hypercalcemic type and endometrial adenocarcinoma in a 49-year-old patient: a very rare case. European Journal of Gynaecological Oncology. 2019; 40(6): 1064-1066. doi: 10.12892/ejgo4978.2019

References

[1] Florell S.R., Bruggers C.S., Matlak M., Young R.H., Lowichik A.: “Ovarian small cell carcinoma of the hypercalcemic type in a 14 month old: the youngest reported case”. Med. Pediatr. Oncol., 1999, 32, 304.

[2] Estel R., Hackethal A., Kalder M., Munstedt K.: “Small cell carci-noma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases pub-lished in the literature”. Arch. Gynecol. Obstet., 2011, 284, 1277.

[3] Zaino R., Whitney C., Brady M.F., DeGeest K., Burger R.A., Buller R. E.: “Simultaneously detected endometrial and ovarian carcino-mas—a prospective clinicopathologic study of 74 cases: a gyneco-logic oncology group study”. Gynecol. Oncol., 2001, 83, 355.

[4] Young R.H., Oliva E., Scully R.E.: “Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases”. Am. J. Surg. Pathol., 1994, 18, 1102.

[5] Callegaro-Filho D., Gershenson D.M., Nick A.M., Munsell M.F., Ramirez P.T., Eifel P.J., et al.: “Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases”. Gynecol. Oncol., 2006, 140, 53.

[6] Harrison M.L., Hoskins P., du Bois A., Quinn M., Rustin G.J., Led-ermann, J., et al.: “Small cell of the ovary, hypercalcemic type —analysis of combined experience and recommendation for manage-ment. A GCIG study”. Gynecol. Oncol., 2006, 100, 233.

[7] Ramos P., Karnezis A.N., Craig D.W., Sekulic A., Russell M.L., Hen-dricks W.P., et al.: “Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4”. Nat. Genet., 2006, 46, 427.

[8] Witkowski L., Donini N., Byler-Dann R., Knost J.A., Albrecht S., Berchuck A., et al.: “The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases”. Fam. Cancer, 2017, 16, 395.

Submission Turnaround Time

Top